Rocket Lab's RKLB Plummets 6.6%: What's Behind the Sudden Drop?

Summary
• Rocket Lab (RKLB) trades at $72.08, down 6.6% from its $77.18 previous close
• Intraday range spans $70.89 to $76.99, with 15.3 million shares traded
• Analysts maintain a 'Buy' rating but project a 26% downside to $53.23
• Benjamin Graham's fundamental analysis highlights critical weaknesses in sales and earnings growth
Rocket Lab’s sharp intraday decline has ignited a frenzy of speculation, with the stock trading near its 52-week low of $14.71. The move defies recent sector optimism and analyst bullishness, raising urgent questions about valuation sustainability and market sentiment shifts.

Benjamin Graham's Red Flags and Analyst Divergence Fuel Volatility
The stock’s collapse stems from conflicting signals between fundamental analysis and analyst projections. Benjamin Graham’s Value Investor model flags RKLB’s failure in sales growth (FAIL) and long-term EPS growth (FAIL), despite its 78% RSI suggesting overbought conditions. This divergence creates a toxic mix: while analysts project a $53.23 price target, the Graham analysis underscores structural weaknesses in revenue generation and earnings momentum. The recent $816M defense contract win appears to have triggered profit-taking, with traders capitalizing on the 118% YTD rally before fundamentals catch up to the price action.

Aerospace & Defense Sector Mixed as Rocket Lab Diverges from LMT's Steady Performance
While the Aerospace & Defense sector remains elevated on defense spending optimism, Rocket Lab’s performance starkly contrasts with sector leader Lockheed Martin (LMT), which trades down 0.8%. The sector’s recent gains from Trump’s executive order and SpaceX IPO speculation have not translated to RKLB, which faces unique valuation pressures. LMT’s stable -199 P/E ratio versus RKLB’s -199.23 P/E highlights differing market perceptions of growth sustainability in the space industry.

Bearish Options Playbook: Capitalizing on RKLB’s Volatility with High-Leverage Contracts
• MACD: 6.38 (above signal line 3.40), RSI: 78.68 (overbought), Bollinger Bands: $80.32 (upper), $56.21 (middle), $32.11 (lower)
• 200-day MA: $40.36 (far below current price), Support/Resistance: $41.76–$42.53 (30D), $46.96–$48.18 (200D)
• Turnover Rate: 2.59% (healthy liquidity), Dynamic P/E: -199.23 (negative earnings)
• Key Levels: Watch $70.89 (intraday low) and $56.21 (Bollinger middle band) for directional clues
• Sector Correlation: Divergence from LMT’s -0.8% suggests RKLB’s move is stock-specific
• Options Liquidity: 239,500 shares traded in RKLB20260102C60 (strike $60) and 66,173 in RKLB20260102P64 (strike $64)

Trading Outlook: With RSI at 78.68 and MACD above the signal line, the stock is technically overbought but structurally weak. The 200-day MA at $40.36 suggests a long-term bearish bias, but near-term volatility offers options-driven opportunities. Aggressive bears should prioritize RKLB20260102P64 for its high leverage and liquidity, while RKLB20260102P65 offers a slightly safer entry with comparable reward.

Top Options Contracts:
1. RKLB20260102P64 (Put):
• Strike: $64, Expiry: 2026-01-02, IV: 72.72%, Leverage: 164.02%, Delta: -0.1194, Theta: -0.0496, Gamma: 0.0256, Turnover: 67,897
• IV: High volatility premium, Leverage: Magnifies downside potential, Delta: Moderate sensitivity to price moves, Theta: Rapid time decay favors short-term bearish bets, Gamma: Responsive to price swings
• This put contract offers asymmetric upside in a 5% downside scenario (ST = $68.64): Payoff = max(0, $64 - $68.64) = $0. However, the 72.72% IV and 164.02% leverage create a volatility buffer. Ideal for aggressive short-term bearish positioning.
2. RKLB20260102P65 (Put):
• Strike: $65, Expiry: 2026-01-02, IV: 71.78%, Leverage: 126.61%, Delta: -0.1477, Theta: -0.0521, Gamma: 0.0301, Turnover: 55,536
• IV: Slightly lower but still robust, Leverage: High reward-to-risk ratio, Delta: Stronger downside sensitivity, Theta: Aggressive time decay, Gamma: Enhanced responsiveness to price acceleration
• This contract provides a 5% downside payoff of $1.36 (max(0, $65 - $68.64)). The 71.78% IV and 126.61% leverage create a compelling risk-reward profile for traders expecting a breakdown below $70.89.

If $70.89 breaks, RKLB20260102P64 offers short-side potential.

Backtest Rocket Lab Stock Performance
The backtest of RKLB's performance after an intraday plunge of at least -7% from 2022 to the present shows favorable short-to-medium-term gains. The 3-Day win rate is 55.99%, the 10-Day win rate is 52.48%, and the 30-Day win rate is 57.64%, indicating a higher probability of positive returns in the immediate aftermath of the plunge. The maximum return during the backtest was 16.78% over 30 days, suggesting that while there is volatility, RKLB can exhibit strong recovery gains.

RKLB at Crossroads: Watch $70.89 Support and LMT's Resilience for Clarity
Rocket Lab’s 6.6% intraday drop has created a critical inflection point, with technical indicators and fundamental analysis pointing to divergent outcomes. The stock’s proximity to its 52-week low and Benjamin Graham’s red flags suggest caution, but the sector’s optimism and analyst buy ratings leave room for a rebound. Immediate focus should be on the $70.89 intraday low as a support level and the performance of sector leader Lockheed Martin (-0.8%), which could signal broader industry sentiment. For traders, the RKLB20260102P64 put offers a high-leverage, high-liquidity play on a potential breakdown, while longer-term investors should monitor earnings momentum and contract execution. Action Alert: Position short-term puts if $70.89 breaks, and watch LMT’s resilience for sector-wide clues.